Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
(Z)-ethyl 3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate methanesulfonate is a direct thrombin inhibitor used in clinical practice and a new type of oral anticoagulant. Its mechanism of action is through reversible and strong competition to bind to the specific binding site of thrombin fibrin, so that fibrin production is blocked, thereby inhibiting the formation of thrombus. Mechanism of action Dab etexilate mesylate is the prodrug of dab, which is converted into active dabigatrn after being metabolized in the body. Compared with warfarin, dab etexilate mesylate does not require frequent monitoring of coagulation function and dosage adjustment during the treatment process, and there is less interaction between drugs and is not affected by eating, thereby improving the patient's medication compliance.
Product Categories : API Intermediates > Intermediate for CAS 872728-81-9
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.